Other human ovarian cancer cell lines expressing FOXL2, such as KGN, harbor the pathognomonic FOXL2 mutation p.Cys134Trp [50], imposing other limitations to the recapturing of fetal ovarian development. This evidence concerns the gene FOXL2 and ovarian carcinoma.